At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 15 enrolled
Drug / intervention
Octreotide +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults
In Brief
A Early Phase 1 clinical trial evaluating Octreotide, Insulin, and 1 other intervention for Vascular Stiffness and Insulin Sensitivity. Completed, enrolled 15 participants across 1 site.
Detailed Summary
The investigators are studying the effects of Hyperglycemia on vascular function and insulin sensitivity on healthy adults
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVascular Stiffness, Insulin Sensitivity
CountriesUnited States
Timeline
Early Ph 1CompletedFinished
20192020202120222023202420252026
First PostedMay 2018
Enrollment StartFeb 2019
Primary CompletionApr 2021
TodayJul 2026
First PostedMay 9, 2018
Enrollment StartFeb 4, 2019
Primary CompletionApr 1, 2021
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.1 years ago
Interventions
Octreotidedrug
we are using it to block insulin secretion from the pancreas
Insulindrug
we are using to replace basal insulin and in two protocols to raise insulin concentrations during the insulin clamp
Dextrose 20% solutiondrug
We are using dextrose to maintain glycemia level